ADVENZYMES — Advanced Enzyme Technologies Income Statement
0.000.00%
Last trade - 00:00
- IN₹40.96bn
- IN₹37.13bn
- IN₹5.41bn
- 96
- 20
- 91
- 84
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,196 | 4,440 | 5,018 | 5,294 | 5,406 |
Cost of Revenue | |||||
Gross Profit | 3,155 | 3,334 | 3,687 | 3,805 | 3,602 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,587 | 2,671 | 2,940 | 3,629 | 4,197 |
Operating Profit | 1,609 | 1,769 | 2,078 | 1,665 | 1,209 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,620 | 1,792 | 2,104 | 1,711 | 1,404 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,159 | 1,330 | 1,515 | 1,238 | 1,039 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,111 | 1,293 | 1,462 | 1,196 | 1,056 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,111 | 1,293 | 1,462 | 1,196 | 1,056 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.94 | 11.6 | 12.8 | 10.6 | 9.81 |
Dividends per Share |